Matches in Nanopublications for { ?s ?p "[AVI-4126, a neutral antisense phosphorodiamidate morpholino oligomer (PMO) has been identified to specifically inhibit c-MYC expression in multiple disease models and identified in Phase I clinical studies to be safe and bioavailable in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP688873.RAdJ6ZI4sdhi9JOc6vIA_y49Q_WIwDKF0SHst1ppqb1hc130_assertion description "[AVI-4126, a neutral antisense phosphorodiamidate morpholino oligomer (PMO) has been identified to specifically inhibit c-MYC expression in multiple disease models and identified in Phase I clinical studies to be safe and bioavailable in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP688873.RAdJ6ZI4sdhi9JOc6vIA_y49Q_WIwDKF0SHst1ppqb1hc130_provenance.
- assertion description "[AVI-4126, a neutral antisense phosphorodiamidate morpholino oligomer (PMO) has been identified to specifically inhibit c-MYC expression in multiple disease models and identified in Phase I clinical studies to be safe and bioavailable in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP581804.RApx0Odnf6CStawzA1jujrb0ExGlSm6AQ3LI4gO0gHW1Y130_assertion description "[AVI-4126, a neutral antisense phosphorodiamidate morpholino oligomer (PMO) has been identified to specifically inhibit c-MYC expression in multiple disease models and identified in Phase I clinical studies to be safe and bioavailable in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581804.RApx0Odnf6CStawzA1jujrb0ExGlSm6AQ3LI4gO0gHW1Y130_provenance.
- NP646514.RAl07QpmdnlHOA2lTGe2j8wIXW5DjX5rMY7jZ977ookgs130_assertion description "[AVI-4126, a neutral antisense phosphorodiamidate morpholino oligomer (PMO) has been identified to specifically inhibit c-MYC expression in multiple disease models and identified in Phase I clinical studies to be safe and bioavailable in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646514.RAl07QpmdnlHOA2lTGe2j8wIXW5DjX5rMY7jZ977ookgs130_provenance.